Epigral Chairman and Managing Director Maulik Patel told PTI the company ended fiscal 2026 with revenue of around Rs 2,500-2,530 crore and expects about Rs 2,900 crore this financial year.
The company is doubling CPVC resin capacity from 75,000 t/y to 150,000 t/y and epichlorohydrin capacity from 50,000 t/y to 100,000 t/y at its existing units in Dahej, Gujarat.
Patel said the capacity increases will start adding to revenue from next year. The company expects to double revenue to around Rs 5,000 crore by 2030-31.
Epigral is an Indian producer of chlorinated polyvinyl chloride and related chlor-alkali derivatives used in pipes, coatings and other applications.
The expansion adds to a broader wave of Indian chemical capacity investment aimed at import substitution and export growth.
